Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cancer genome landscapes.

Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW.

Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122. Review.

2.

Our changing view of the genomic landscape of cancer.

Bell DW.

J Pathol. 2010 Jan;220(2):231-43. doi: 10.1002/path.2645. Review.

3.

Molecular pathways in tumor progression: from discovery to functional understanding.

Ali MA, Sjöblom T.

Mol Biosyst. 2009 Sep;5(9):902-8. doi: 10.1039/b903502h. Review.

PMID:
19668850
4.

Focus issue: From genomic mutations to oncogenic pathways.

Gough NR.

Sci Signal. 2013 Mar 26;6(268):eg3. doi: 10.1126/scisignal.2004149.

5.

DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.

Hua X, Xu H, Yang Y, Zhu J, Liu P, Lu Y.

Am J Hum Genet. 2013 Sep 5;93(3):439-51. doi: 10.1016/j.ajhg.2013.07.003.

6.

Deciphering the genetic landscape of cancer--from genes to pathways.

Copeland NG, Jenkins NA.

Trends Genet. 2009 Oct;25(10):455-62. doi: 10.1016/j.tig.2009.08.004. Review.

PMID:
19818523
7.

[Current topics in mutations in the cancer genome].

Iwaya T, Mimori K, Wakabayashi G.

Nihon Geka Gakkai Zasshi. 2012 Mar;113(2):185-90. Review. Japanese.

PMID:
22582578
8.

From human genome to cancer genome: the first decade.

Wheeler DA, Wang L.

Genome Res. 2013 Jul;23(7):1054-62. doi: 10.1101/gr.157602.113. Review.

9.

Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations.

Youn A, Simon R.

BMC Bioinformatics. 2013 Dec 13;14:363. doi: 10.1186/1471-2105-14-363.

10.

The landscape of cancer genes and mutational processes in breast cancer.

Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A; Oslo Breast Cancer Consortium (OSBREAC)., Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, van 't Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SA, Salomon AV, Børresen-Dale AL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR.

Nature. 2012 May 16;486(7403):400-4. doi: 10.1038/nature11017.

11.

Comprehensive identification of mutational cancer driver genes across 12 tumor types.

Tamborero D, Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Kandoth C, Reimand J, Lawrence MS, Getz G, Bader GD, Ding L, Lopez-Bigas N.

Sci Rep. 2013 Oct 2;3:2650. doi: 10.1038/srep02650.

12.

Patterns of somatic mutation in human cancer genomes.

Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR.

Nature. 2007 Mar 8;446(7132):153-8.

13.

The genomic landscapes of human breast and colorectal cancers.

Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B.

Science. 2007 Nov 16;318(5853):1108-13.

14.

A comprehensive catalogue of somatic mutations from a human cancer genome.

Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordóñez GR, Bignell GR, Ye K, Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, Mudie LJ, Ning Z, Royce T, Schulz-Trieglaff OB, Spiridou A, Stebbings LA, Szajkowski L, Teague J, Williamson D, Chin L, Ross MT, Campbell PJ, Bentley DR, Futreal PA, Stratton MR.

Nature. 2010 Jan 14;463(7278):191-6. doi: 10.1038/nature08658.

15.

Big science: The cancer genome challenge.

Ledford H.

Nature. 2010 Apr 15;464(7291):972-4. doi: 10.1038/464972a. No abstract available.

PMID:
20393534
16.

The mutational landscape of phosphorylation signaling in cancer.

Reimand J, Wagih O, Bader GD.

Sci Rep. 2013 Oct 2;3:2651. doi: 10.1038/srep02651.

17.

The mini-driver model of polygenic cancer evolution.

Castro-Giner F, Ratcliffe P, Tomlinson I.

Nat Rev Cancer. 2015 Nov;15(11):680-5. doi: 10.1038/nrc3999. Review.

PMID:
26456849
18.

Design and analysis issues in genome-wide somatic mutation studies of cancer.

Parmigiani G, Boca S, Lin J, Kinzler KW, Velculescu V, Vogelstein B.

Genomics. 2009 Jan;93(1):17-21. doi: 10.1016/j.ygeno.2008.07.005. Review.

19.

Implications of genetic heterogeneity in cancer.

Schmitt MW, Prindle MJ, Loeb LA.

Ann N Y Acad Sci. 2012 Sep;1267:110-6. doi: 10.1111/j.1749-6632.2012.06590.x.

20.

The Path to Cancer --Three Strikes and You're Out.

Vogelstein B, Kinzler KW.

N Engl J Med. 2015 Nov 12;373(20):1895-8. doi: 10.1056/NEJMp1508811.

PMID:
26559569
Items per page

Supplemental Content

Support Center